A trial examined the benefit of treating GBM, involving NovoCure and mentioning ISS as a securities litigation firm.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A trial examined the benefit of treating GBM, involving NovoCure and mentioning ISS as a securities litigation firm.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
ISS
Danish facility management service provider